# High (100mg) Versus Standard (60mg) Loading Dose of Prasugrel in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI)

> **NCT01835353** · PHASE3 · COMPLETED · sponsor: **University of Patras** · enrollment: 82 (actual)

## Conditions studied

- Platelet Reactivity

## Interventions

- **DRUG:** Prasugrel 100mg loading dose
- **DRUG:** Prasugrel 60mg loading dose

## Key facts

- **NCT ID:** NCT01835353
- **Lead sponsor:** University of Patras
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2013-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01835353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01835353, "High (100mg) Versus Standard (60mg) Loading Dose of Prasugrel in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01835353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*